Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 8
1987 17
1988 40
1989 78
1990 71
1991 87
1992 112
1993 83
1994 129
1995 141
1996 136
1997 130
1998 155
1999 172
2000 143
2001 165
2002 149
2003 140
2004 145
2005 156
2006 116
2007 110
2008 86
2009 115
2010 114
2011 104
2012 104
2013 75
2014 89
2015 104
2016 79
2017 61
2018 58
2019 34
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

3,360 results
Results by year
Filters applied: . Clear all
Page 1
Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis.
Qi Q, et al. Int J Clin Pharmacol Ther 2015 - Review. PMID 26329348
This study aims to evaluate the effectiveness and tolerability of esomeprazole and omeprazole in patients with gastroesophageal reflux disease (GERD). ...These results revealed a significant difference between esomeprazole vs. omeprazole (RR=1.06, 95% CI [1.01, 1.10], I2=72%, p=0.01) by subgroup according to dosage by random effects model, and a significant difference between esomeprazole 40 mg vs. omeprazole 20 mg (RR=1.07, 95% CI [1.004, 1.14], I2=78%, p=0.04) based on healing rate as determined by endoscopy, using a random effects model. ...
This study aims to evaluate the effectiveness and tolerability of esomeprazole and omeprazole in patients with gastroesophageal reflu …
Introduction
Illueca M. J Pediatr Gastroenterol Nutr 2015. PMID 26422092
Re-evaluation of the regulation of omeprazole in racehorses: An evidence-based approach.
Viljanto M, et al. J Vet Pharmacol Ther 2018. PMID 29468684
This ensures that horses do not compete under the influence of any drugs, including omeprazole, a therapeutic medication used to treat equine gastric ulcer syndrome. In this study, pharmacokinetic data were produced in equine plasma and urine following an oral administration of 4 mg/kg of generic buffered formulation of omeprazole to six Thoroughbred horses in five daily doses to determine an appropriate screening limit and detection time in equine plasma and to assess whether the current detection time of 72 hr in equine urine would be applicable when an alternative omeprazole product is administered. ...
This ensures that horses do not compete under the influence of any drugs, including omeprazole, a therapeutic medication used …
Esomeprazole
Spencer CM and Faulds D. Drugs 2000 - Review. PMID 10983736
Esomeprazole, a new proton pump inhibitor, is the S-isomer of omeprazole and is the first such inhibitor to be developed as a single isomer. ...Similarly, symptom-driven on-demand use of esomeprazole effectively controlled symptoms of GORD (heartburn) for 6 months in 2 large placebo-controlled trials. ...
Esomeprazole, a new proton pump inhibitor, is the S-isomer of omeprazole and is the first such inhibitor to be developed as a single …
Omeprazole.
Maton PN. N Engl J Med 1991 - Review. PMID 2002819
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies
Attwood SE, et al. Aliment Pharmacol Ther 2015. PMID 25858519 Free article.
The primary efficacy results of the SOPRAN study, comparing long-term omeprazole use with open ARS, and the LOTUS study, comparing long-term esomeprazole use with laparoscopic ARS, have been reported. A secondary objective of these studies was to address the long-term safety of these respective therapeutic strategies and thereby provide a valid scientific platform for assessing long-term PPI safety. ...
The primary efficacy results of the SOPRAN study, comparing long-term omeprazole use with open ARS, and the LOTUS study, compa …
Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome.
Bush J, et al. Equine Vet J 2018 - Clinical Trial. PMID 28555939
OBJECTIVES: To test the hypothesis that aloe vera would be noninferior to omeprazole in the treatment of equine gastric ulcer syndrome. ...CONCLUSIONS: Treatment with aloe vera was inferior to treatment with omeprazole....
OBJECTIVES: To test the hypothesis that aloe vera would be noninferior to omeprazole in the treatment of equine gastric ulcer syndrom …
Comparative efficacy of esomeprazole and omeprazole: Racemate to single enantiomer switch.
Asghar W, et al. Daru 2015. PMID 26573220 Free PMC article.
There was no significant difference in the therapeutic success between omeprazole and S-omeprazole as a part of triple therapy for the treatment of H. pylori in both intention-to-treat (OR', 1.06; CI, 0.83, 1.36; p = 0.63) as well as per-protocol analysis (OR', 1.07; CI, 0.84, 1.36; p = 0.57). ...CONCLUSION: The therapeutic benefit of chiral switch of omeprazole is questionable considering the substantially greater economic burden involved....
There was no significant difference in the therapeutic success between omeprazole and S-omeprazole as a part of triple …
Omeprazole.
Langman MJ. BMJ 1991. PMID 1680515 Free PMC article.
3,360 results
Jump to page
Feedback